Kalb Michael Wayne — SEC Form 4 filings
SEC reporting owner CIK 1678248. 5 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-11-25 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Financial Officer | 5 | — | — | 20 |
Form 4 filings — Kalb Michael Wayne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to issuer (D): 13,665 @ $31.50 · Disposition to issuer (D): 257,214 (derivative) @ $0 · Disposition to issuer (D): 169,248 (derivative) @ $0 · Disposition to issuer (D): 131,536 (derivative) @ $0 · Disposition to issuer (D): 21,416 (derivative) @ $0 · Disposition to issuer (D): 13,788 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-06 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 7,139 · Tax withholding (F): 2,080 · Option exercise (M): 7,139 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,894 · Tax withholding (F): 2,485 · Grant/award (A): 131,536 (derivative) @ $0 · Grant/award (A): 39,701 (derivative) @ $0 · Option exercise (M): 6,894 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 7,138 · Tax withholding (F): 2,941 · Option exercise (M): 7,138 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/award (A): 169,248 (derivative) @ $0 · Grant/award (A): 20,682 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1678248 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →